Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids
NASHVILLE — Youth with attention-deficit/hyperactivity disorder (ADHD) saw mildly different growth trajectories with certain popular medications, researchers reported. Compared with youth prescribed lisdexamfetamine dimesylate (LDX; Vyvanse), those who took delayed release/extended-release methylphenidate (DR/ER-MPH; Jornay PM) saw a greater weight trajectory in the first year after starting treatment (estimated post-index slope 2.65 for LDX vs 7.22, […]